RNS
VRTX icon

Robert N. Shapiro’s Vertex Pharmaceuticals VRTX Stock Holding History

Robert N. Shapiro’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$55K Buy
456
+136
+43% +$15.3K 0.01% 442
2014
Q3 		$36K Sell
320
-305
-49% -$29K 0.01% 534
2014
Q2 		$59K Buy
625
+250
+67% +$17.5K 0.01% 444
2014
Q1 		$27K Hold
375
– – 0.01% 549
2013
Q4 		$28K Hold
375
– – 0.01% 550
2013
Q3 		$28K Sell
375
-123
-25% -$9.79K ﹤0.01% 724
2013
Q2 		$40K Buy
+498
New +$36.7K 0.01% 615

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Robert N. Shapiro's VRTX Position: Q4 2014 in Review

Robert N. Shapiro increased its Vertex Pharmaceuticals (VRTX) stake by 43% in Q4 2014, buying an estimated $15.3K and bringing the position to 456 shares worth $55K. The position accounts for 0.01% of the portfolio, ranked #442.

Robert N. Shapiro first reported a position in VRTX in Q2 2013 and has held it in 7 quarters since. The position peaked at $59K in Q2 2014. 474 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

  • Robert N. Shapiro held 456 shares of Vertex Pharmaceuticals worth $55K as of Q4 2014.
  • Robert N. Shapiro bought 136 Vertex Pharmaceuticals shares in Q4 2014, an estimated $15.3K.
  • Vertex Pharmaceuticals made up 0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #442 holding.
  • Robert N. Shapiro first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Vertex Pharmaceuticals position peaked at $59K in Q2 2014.
  • 474 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.